Analyst Ratings for Ligand Pharmaceuticals Inc. (LGND)

Updated: 2017-07-28

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was awarded an average rating of Buy from investment analysts following the stock. LGND had previously received a consensus rating of Buy a month ago.

4 analysts declared LGND a buy, 0 gave an overweight rating, 1 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for LGND. The most optimistic analyst gave a price target of 160, implying potential capital gains of 31.95 percent. The most pessimistic analyst gave a price target of 103, implying potential capital losses of -15.06 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 5.46 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -21.71 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.73 percent. If we look at the last 90 days instead, we find a net average change of -5.94 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Over the same time period, 1 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.

LGND has traded between a high of 139.79 and a low of 87.50 over the past year. Currently the stock is 38.58 percent higher than its low, and 13.26 percent below the high. LGND has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The LGND value stock report compares LGND to some of its peers using value stock charts. The market cap of LGND is $2.54 billion. LGND will post this quarters earnings in days, on 0000-00-00.